In the world we live in today, a holistic view of health and wellbeing must include mental and emotional health alongside physical health. To provide client-centered healthcare that is tailored to the unique needs of queer men, clinicians and healthcare providers should know how queerness intersects with various facets of men's health. This factsheet takes an intersectional lens and looks at different factors such as HIV status, trauma, housing, race, age, ability, class, body image, substance use, etc. and makes suggestions for coping as well as improvements to the healthcare system.
Mpox: Outbreak, Response, and Vaccine Effectiveness (webinar recording)

- Resources
- >
- Mpox: Outbreak, Response, and Vaccine Effectiveness (webinar recording)
Mpox: Outbreak, Response, and Vaccine Effectiveness (webinar recording)
August 08, 2023
In the Spring of 2022, an explosive global epidemic of mpox infection emerged, primarily in gay, bisexual and other men who have sex with men (GBM). Ontario was among the first jurisdictions to see large numbers of cases, and a variety of civil society, clinical, public health and research activities rapidly mobilized in response. This session will review current knowledge about the epidemic, including key epidemiologic and clinical features while further highlighting emerging findings about medical countermeasures including tecovirimat for therapy and Imvamune™ vaccine for prevention. A critical aspect of the response that will be highlighted is the importance of grounding public health work in community engagement principles.
By the end of this session, participants will be able to:
• Describe the evolving epidemiology of mpox in Ontario and globally with a focus on the 2022 outbreak
• Identify the key clinical characteristics of mpox infection
• Discuss recent evidence and advances in our understanding of medical countermeasures including antivirals and vaccines against mpox
Presenter(s): Dr. Darrell H. S. Tan and Dane Griffiths (GMSH)
The presentation can be found here: https://www.publichealthontario.ca/en/Education-and-Events/Presentations#q=1
Related resources to check out
24 April 2025
FACTSHEET: Prostate health, care, treatment for prostate cancer in 2SGBTQ men & trans women
As people with prostates (PwP) get older, they are more likely to have prostatic conditions such as BPH, prostatitis, and prostate cancer. Screening for prostate cancer can be considered using the prostate-specific antigen (PSA) test alone, or in conjunction with a digital rectal exam (in which the clinician uses a finger through the rectum to feel for prostate growths)—guidelines vary. Per the Canadian Urological Association in 2022, the recommended age to consider starting for prostate cancer screening is around 50 years of age for those who are at average risk. However, it is recommended that those at higher risk, including African, Caribbean, and Black (ACB) men, consider screening for prostate cancer earlier at age 45.